| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.074 | 0.2 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |